Novel Antithrombotics and Lower Risk of Intraocular Bleeding

Novel antithrombotics such as dabigatran or rivaroxaban are associated, in some instances, with a decreased risk of intraocular hemorrhage compared with traditional anticoagulant therapy.
Reuters Health Information

Full Story →